Silent Crohn’s disease may have little or no symptoms. It's important to monitor disease activity and treat the condition to ...

Women are just as likely to get Crohn’s disease as men, but their symptoms may differ in some ways. This article looks at what these symptoms are, how to treat them, and how to get support if ...

Crohn’s disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes inflammation in the digestive tract, which can lead to numerous ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ...

If you have Crohn’s disease, symptoms such as abdominal pain and frequent bowel movements can prevent you from getting enough quality sleep and rest. These are just some of the reasons why ...

Even before the rise to notoriety of men such as Simon Cowell and 'Nasty ... In fact, she had Crohn's disease, an inflammatory bowel condition that causes a range of distressing symptoms.

Crohn s disease is a chronic inflammatory disease of the gastrointestinal tract, mostly affecting the ileum. The inflammation can extend through the intestinal wall and tends to be asymmetric and ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...

Crohn’s disease and ulcerative colitis are both inflammatory bowel diseases with similar symptoms. However, some key differences include the areas they affect, diagnostic tools, and treatment plans.

Many different types of medications help treat Crohn’s disease, including a group of drugs known as biologics. Doctors often prescribe them for people with moderate to severe symptoms caused by ...

Researchers retrospectively included 223 patients (median age, 38 years; 49.8% men) with active luminal Crohn's disease who did not respond to conventional treatment to assess the real-world ...

Ustekinumab treatment may have better persistence than anti-TNF therapy as a second-line therapy in patients with Crohn's disease, along with improvements seen in clinical remission rates.